| Name | Title | Contact Details |
|---|
With a unique Platform Approach to AI implementation, Blackstraw custom-delivers enterprise-grade AI solutions that impact business outcomes fast.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
MedPro Systems is a trusted partner for the Healthcare and Life Sciences industries to solve difficult challenges in managing, validating, and enriching healthcare practitioner (HCP) and healthcare organization (HCO) data attributes.
LandPick - Premium Multipurpose Landing Pages Pack
Credible is committed to improving the quality of care and lives in behavioral health for clients, families, providers, and management. We strive to deliver the highest quality Behavioral Health technology at a great value. Remaining focused on providers, be they Community-based, Clinic-based, Youth or Residential, Credible differentiates on innovation, value, and customer service.